BeStock  
Stocks › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2809Biotechnology
$21.35 +$0.08 (+0.38%)
Market closed · Oct 6, 5:40 am ET · Last extended-hours $21.35 0.00%
Open$21.57
Prev close$21.27
Day range$19.83 – $22.02
Volume889.0K
Market cap$1.92B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.5x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average -12.9x

Price / book-20.0x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average -21.3x

Morningstar fair value estimate

Fair value$31.44
Price vs. fair value-32.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -20.05 – -21.33 81% (pricier than usual) –
PE -3.46 -15.84 -12.93 81% (pricier than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$31.44
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on BRVE.

Leave a comment

Scroll to Top